Moody’s affirms Mount Sinai Medical Center of Florida’s “Baa1” rating

Moody’s Investors service has affirmed “Baa1” long-term ratings for Miami-based Mount Sinai Medical Center’s bonds, in conjunction with the hospital’s plan to up the par size on their planned issuance of revenue and refunding bonds from $165.62 million to $176.27 million.

Advertisement

Moody’s also affirmed a stable rating outlook for MSMC. The rating affirmation reflects the hospital’s improved financial performance in recent years. Operating cash flow increased to more than $50 million in each of the last four fiscal years. Additionally, MSMC increased its cash position to more than $281 million, or 228 days, as of Dec. 31.

Furthermore, MSMC has generally strong demand and a solidly growing footprint, and its multi-year strategy with well-executed operational initiatives has positioned the organization for continuing growth, according to Moody’s.

More articles on hospital finance:
Fitch affirms “A+” Gunderson Lutheran bond rating
SCL Health’s operating margin falls to 2.4%
Moody’s affirms Saint Mary’s Hospital’s ‘Ba2’ rating

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.